AVANIR PHARMACEUTICALS INC's ticker is and the CUSIP is 05348P901. A total of 3 filers reported holding AVANIR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $12,253,000 | +78.7% | 722,900 | +25.7% | 0.18% | +74.5% |
| Q3 2014 | $6,855,000 | +431.4% | 575,100 | +151.4% | 0.11% | +430.0% |
| Q2 2014 | $1,290,000 | +33.1% | 228,800 | -13.3% | 0.02% | +25.0% |
| Q1 2014 | $969,000 | +62.9% | 264,000 | +49.0% | 0.02% | +77.8% |
| Q4 2013 | $595,000 | +191.7% | 177,200 | +267.6% | 0.01% | +125.0% |
| Q3 2013 | $204,000 | +32.5% | 48,200 | +43.9% | 0.00% | 0.0% |
| Q2 2013 | $154,000 | – | 33,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,663 | $559,000 | 0.04% |
| GROUP ONE TRADING, L.P. | 177,200 | $595,000 | 0.01% |
| Citadel Advisors | 54,400 | $183,000 | 0.00% |